
The US Food and Drug Administration has shown the green light to US firm EnteroMedics’ new obesity device VBLOC that …
Amphista doses first patient in AML trial of protein degrader
Jennings becomes President of Beckman Coulter Diagnostics
Boyds expands Regulatory Affairs team to support growing demand

